These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

231 related items for PubMed ID: 17653896

  • 21. Association of Ki67 index with prognosis for intermediate-grade canine cutaneous mast cell tumours.
    Maglennon GA, Murphy S, Adams V, Miller J, Smith K, Blunden A, Scase TJ.
    Vet Comp Oncol; 2008 Dec; 6(4):268-74. PubMed ID: 19178685
    [Abstract] [Full Text] [Related]

  • 22. Ki-67 proliferative index predicts progression-free survival of patients with well-differentiated ileal neuroendocrine tumors.
    Dhall D, Mertens R, Bresee C, Parakh R, Wang HL, Li M, Dhall G, Colquhoun SD, Ines D, Chung F, Yu R, Nissen NN, Wolin E.
    Hum Pathol; 2012 Apr; 43(4):489-95. PubMed ID: 21937080
    [Abstract] [Full Text] [Related]

  • 23. Relation of microvessel density with microvascular invasion, metastasis and prognosis in renal cell carcinoma.
    Yildiz E, Ayan S, Goze F, Gokce G, Gultekin EY.
    BJU Int; 2008 Mar; 101(6):758-64. PubMed ID: 18070177
    [Abstract] [Full Text] [Related]

  • 24.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 25. Prognostic significance of Ki-67 antigen expression in non-Hodgkin's lymphomas.
    Szczuraszek K, Mazur G, Jeleń M, Dziegiel P, Surowiak P, Zabel M.
    Anticancer Res; 2008 Mar; 28(2A):1113-8. PubMed ID: 18507062
    [Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27. Aneuploidy and overexpression of Ki67 and p53 as markers for neoplastic progression in Barrett's esophagus: a case-control study.
    Sikkema M, Kerkhof M, Steyerberg EW, Kusters JG, van Strien PM, Looman CW, van Dekken H, Siersema PD, Kuipers EJ.
    Am J Gastroenterol; 2009 Nov; 104(11):2673-80. PubMed ID: 19638963
    [Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31. Circulating markers of prognosis and response to treatment in patients with midgut carcinoid tumours.
    Turner GB, Johnston BT, McCance DR, McGinty A, Watson RG, Patterson CC, Ardill JE.
    Gut; 2006 Nov; 55(11):1586-91. PubMed ID: 16556667
    [Abstract] [Full Text] [Related]

  • 32. Impact of several histopathological prognosticators and local tumour extension on oncological outcome in pT3b/c N0M0 renal cell carcinoma.
    Roos FC, Weirich J, Victor A, Elsässer A, Brenner W, Biesterfeld S, Hampel C, Thüroff JW.
    BJU Int; 2009 Aug; 104(4):461-9. PubMed ID: 19338563
    [Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37. Prognostic factors of long-term outcome in gastroenteropancreatic neuroendocrine tumours.
    Pape UF, Berndt U, Müller-Nordhorn J, Böhmig M, Roll S, Koch M, Willich SN, Wiedenmann B.
    Endocr Relat Cancer; 2008 Dec; 15(4):1083-97. PubMed ID: 18603570
    [Abstract] [Full Text] [Related]

  • 38.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 39.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 40. Role and prognostic significance of the Ki-67 index in non-Hodgkin's lymphoma.
    Broyde A, Boycov O, Strenov Y, Okon E, Shpilberg O, Bairey O.
    Am J Hematol; 2009 Jun; 84(6):338-43. PubMed ID: 19384938
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 12.